Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Total Debt: 2017

  • Aclaris Therapeutics' Total Debt was N/A to $590,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $590,000, marking a year-over-year change of. This contributed to the annual value of $590,000 for FY2017, which is N/A change from last year.
  • Per Aclaris Therapeutics' latest filing, its Total Debt stood at $590,000 for Q4 2017.
  • Over the past 5 years, Aclaris Therapeutics' Total Debt peaked at $590,000 during Q4 2017, and registered a low of $590,000 during Q4 2017.
  • For the 1-year period, Aclaris Therapeutics' Total Debt averaged around $590,000, with its median value being $590,000 (2017).